000 01404 a2200385 4500
005 20250513084008.0
264 0 _c19960222
008 199602s 0 0 eng d
022 _a0009-9236
024 7 _a10.1016/S0009-9236(96)90019-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLee, B L
245 0 0 _aAtovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cJan 1996
300 _a14-21 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAnalysis of Variance
650 0 4 _aAntiviral Agents
_xblood
650 0 4 _aAtovaquone
650 0 4 _aCross-Over Studies
650 0 4 _aGlucuronates
_xantagonists & inhibitors
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNaphthoquinones
_xpharmacology
650 0 4 _aZidovudine
_xblood
700 1 _aTäuber, M G
700 1 _aSadler, B
700 1 _aGoldstein, D
700 1 _aChambers, H F
773 0 _tClinical pharmacology and therapeutics
_gvol. 59
_gno. 1
_gp. 14-21
856 4 0 _uhttps://doi.org/10.1016/S0009-9236(96)90019-3
_zAvailable from publisher's website
999 _c8548102
_d8548102